SHARED CARE AGREEMENT Name of medicine lisdexamfetamine Indication For attention deficit hyperactivity disorder (ADHD) in adults Version: 2.0 Approval date: October 2016 Review date: October 2019Shared Care Agreement • February 13th, 2017
Contract Type FiledFebruary 13th, 2017This Shared Care Agreement should be used for patients under the care of adult psychiatry services. The Shared Care Agreement lisdexamfetamine for attention deficit hyperactivity disorder (ADHD) in children 6 years and over should be used for patients under the care of NHS Lothian Child and Adolescent Mental Health Services.